Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.00% | 205.10 | 1.2% | $477.70m | |
| GILD | Gilead Sciences, Inc. | 0.91% | 75.51 | 0.9% | $401.46m | |
| BIIB | Biogen Inc. | 1.22% | 345.41 | 1.3% | $352.23m | |
| CELG | Celgene Corporation | -0.66% | 87.72 | 1.2% | $341.18m | |
| ILMN | Illumina, Inc. | 0.52% | 358.16 | 3.5% | $248.76m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.78% | 390.28 | 2.6% | $232.51m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.24% | 180.08 | 1.9% | $168.98m | |
| EXAS | Exact Sciences Corporation | 1.72% | 76.28 | 25.3% | $162.68m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.43% | 147.59 | 16.4% | $129.44m | |
| A | Agilent Technologies, Inc. | -0.58% | 70.72 | 1.5% | $124.93m | |
| VKTX | Viking Therapeutics, Inc. | -4.06% | 18.20 | 0.9% | $115.92m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.10% | 121.99 | 2.0% | $114.40m | |
| NKTR | Nektar Therapeutics | 0.96% | 59.00 | 5.6% | $106.74m | |
| BMRN | BioMarin Pharmaceutical Inc. | -2.55% | 97.84 | 4.4% | $97.41m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -0.67% | 94.57 | 9.7% | $93.14m |
Company Profile
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Biotechnology, Protein Platforms, Diagnostics, and Corporate. The Biotechnology segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and related reagents, as well as in situ hybridization, media and other cell culture products and reagents to the biotechnology research community. The Protein Platforms segment develops, manufactures, and sells tools to simplify protein analysis. The Diagnostics segment includes blood chemistry and blood gas quality controls, hematology instrument controls, diagnostic immunoassays, and other bulk and custom reagents for the in vitro diagnostic market worldwide. The company was founded on 1976 and is headquartered in Minneapolis, MN.